Ibag, Rheann A.

HRN: 25-35-09  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/25/2024
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
06/25/2024
07/02/2024
IV
360 Mg
Q 6 Hours
AGE; PCAP
Waiting Final Action 

Indication:  Empiric    Type of Infection:  PneumoniaIntra-abdominal    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: